Secret Dry Spray Antiperspirant Recalled for Benzene Contamination
The FDA is recalling Secret Dry Spray antiperspirant (Lot #12001458SF) due to benzene contamination. Consumers should stop using the product immediately.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I classification requires a minimum score of 4. No deaths or reported injuries are stated in the source text, so the recall is classified as Severe rather than Critical.
Plain-English summary
Secret Dry Spray antiperspirant (Aluminum chlorohydrate 23.5%, Rose scent, 3.8 oz net weight, NDC 69423-380-10) distributed by Procter & Gamble is being recalled by the FDA as a Class I recall.
The recalled product contains benzene, a chemical contaminant. Benzene is a known hazardous substance.
The affected product carries Lot #12001458SF with an expiration date of 06/30/2023. Distribution includes the USA and Puerto Rico, as well as Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, and Guyana.
Consumers who have purchased this product should discontinue use. For information regarding returns or refunds, contact Procter & Gamble or the FDA.
The recalled product
- Product
- Secret, Dry Spray, Aluminum chlorohydrate 23.5%, Antiperspirant, Rose, Topical spray can Net Wt 3.8 oz (107 g), Dist. by: Procter & Gamble, Cincinnati, OH 45202. NDC: 69423-380-10, UPC 0 37000 79884 2
- Manufacturer
- The Procter & Gamble Company
- Category
- Drug — Antiperspirant
- Hazard
- benzene
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 12001458SF
- Exp 06/30/2023.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27